Final Exam Part 3 (201-261)

40 Questions | By Alexlai67 | Last updated: Dec 14, 2012 | Total Attempts: 49

Questions

Settings

Final exam part 3 (201-261) final exam part 3 (201-261) final exam part 3 (201-261) final exam part 3 (201-261) final exam part 3 (201-261) final exam part 3 (201-261) final exam part 3 (201-261) final exam part 3 (201-261)

More Dna Quizzes

Quiz: A Basic Questions On DNA! Quiz: A Basic Questions On DNA!

DNA, Mutations And Mitosis Quiz DNA, Mutations And Mitosis Quiz

Biology: Are You Ready To Take The DNA Quiz? Biology: Are You Ready To Take The DNA Quiz?

Featured Quizzes

Billie Eilish: The Ultimate Trivia Quiz! Billie Eilish: The Ultimate Trivia Quiz!

Quiz: Which Anime Character Are You Most Like? Quiz: Which Anime Character Are You Most Like?

Which Harry Potter Hogwarts House Do You Belong To Quiz! Which Harry Potter Hogwarts House Do You Belong To Quiz!

Related Topics

Questions and Answers

1.

Newly released RBCs into the blood that still contain some nuclear DNA
- A.
  
  Anisocytosis
- B.
  
  Reticulocytes
- C.
  
  Hematologists
- D.
  
  Erythroblast
- E.
  
  Poikilocytosis
2.

Specialists who evaluate the cellular elements of blood microscopically and analytically
- A.
  
  Anisocytosis
- B.
  
  Reticulocytes
- C.
  
  Hematologists
- D.
  
  Erythroblast
- E.
  
  Poikilocytosis
3.

Large engulfing cells in the tissues that came from monocytes
- A.
  
  Megakaryocyte
- B.
  
  Nongranulocytes
- C.
  
  Myeloblast
- D.
  
  Polymorphonuclear
- E.
  
  Macrophages
4.

Many shaped nucleus or “seg”
- A.
  
  Megakaryocyte
- B.
  
  Nongranulocytes
- C.
  
  Myeloblast
- D.
  
  Polymorphonuclear
- E.
  
  Macrophages
5.

Thrombin
- A.
  
  Activates prothrombin to become thrombin
- B.
  
  The final sticky, stringy product of coagulation
- C.
  
  Activates fibrinogen to become fibrin
- D.
  
  A natural anticoagulant that prevents excessive clotting
- E.
  
  A moving clot
6.

Thromboplastin
- A.
  
  Activates prothrombin to become thrombin
- B.
  
  The final sticky, stringy product of coagulation
- C.
  
  Activates fibrinogen to become fibrin
- D.
  
  A natural anticoagulant that prevents excessive clotting
- E.
  
  A moving clot
7.

Bilirubin
- A.
  
  Condition in which the red blood cell or hemoglobin levels are below normal
- B.
  
  A molecule that has a reddish pigment and is capable of carrying oxygen
- C.
  
  A by-product of RBC breakdown that is sent to the liver
- D.
  
  Protein portion of the hemoglobin molecule
- E.
  
  Iron portion of hemoglobin molecule
8.

Anemia
- A.
  
  Condition in which the red blood cell or hemoglobin levels are below normal
- B.
  
  A molecule that has a reddish pigment and is capable of carrying oxygen
- C.
  
  A by-product of RBC breakdown that is sent to the liver
- D.
  
  Protein portion of the hemoglobin molecule
- E.
  
  Iron portion of hemoglobin molecule
9.

Hemoglobin
- A.
  
  Condition in which the red blood cell or hemoglobin levels are below normal
- B.
  
  A molecule that has a reddish pigment and is capable of carrying oxygen
- C.
  
  A by-product of RBC breakdown that is sent to the liver
- D.
  
  Protein portion of the hemoglobin molecule
- E.
  
  Iron portion of hemoglobin molecule
10.

hematocrit tube layers : buffy layer ??
- A.
  
  Label A
- B.
  
  Label B
- C.
  
  Label C
- D.
  
  Label D
- E.
  
  Label E
11.

Plasma
- A.
  
  Label A
- B.
  
  Label B
- C.
  
  Label C
- D.
  
  Label D
- E.
  
  Label E
12.

Select A
- A.
  
  A
- B.
  
  A
13.

Select A
- A.
  
  A
- B.
  
  A
14.

Select A
- A.
  
  A
- B.
  
  A
15.

Select A
- A.
  
  A
- B.
  
  A
16.

Select A
- A.
  
  A
- B.
  
  A
17.

RBC layer
- A.
  
  Label A
- B.
  
  Label B
- C.
  
  Label C
- D.
  
  Label D
- E.
  
  Label E
18.

Air
- A.
  
  Label A
- B.
  
  Label B
- C.
  
  Label C
- D.
  
  Label D
- E.
  
  Label E
19.

ESR
- A.
  
  16 to 18 sec or 2.0 to 2.5 INR
- B.
  
  0 to 20 mm/hour
- C.
  
  12 to 18 gm/dL
- D.
  
  36% to 55%
20.

ProTime
- A.
  
  16 to 18 sec or 2.0 to 2.5 INR
- B.
  
  0 to 20 mm/hour
- C.
  
  12 to 18 gm/dL
- D.
  
  36% to 55%
21.

HemataSTAT
- A.
  
  Coagulation test
- B.
  
  Sedimentation rate
- C.
  
  Complete blood count
- D.
  
  Hematocrit
- E.
  
  Hemoglobin
22.

ProTime
- A.
  
  16 to 18 sec or 2.0 to 2.5 INR
- B.
  
  0 to 20 mm/hour
- C.
  
  12 to 18 gm/dL
- D.
  
  36% to 55%
23.

HemataSTAT
- A.
  
  Coagulation test
- B.
  
  Sedimentation rate
- C.
  
  Complete blood count
- D.
  
  Hematocrit
- E.
  
  Hemoglobin
24.

SEDIPLAST/Westergren
- A.
  
  Coagulation test
- B.
  
  Sedimentation rate
- C.
  
  Complete blood count
- D.
  
  Hematocrit
- E.
  
  Hemoglobin
25.

Protime
- A.
  
  Coagulation test
- B.
  
  Sedimentation rate
- C.
  
  Complete blood count
- D.
  
  Hematocrit
- E.
  
  Hemoglobin
26.

QBC
- A.
  
  Coagulation test
- B.
  
  Sedimentation rate
- C.
  
  Complete blood count
- D.
  
  Hematocrit
- E.
  
  Hemoglobin
27.

Leukopenia
- A.
  
  Abnormal decrease in RBCs
- B.
  
  Abnormal decrease in WBCs
- C.
  
  Cancer of the WBCs
- D.
  
  Abnormal increase in WBCs
- E.
  
  Abnormal increase in RBCs
28.

Leukocytosis
- A.
  
  Abnormal decrease in RBCs
- B.
  
  Abnormal decrease in WBCs
- C.
  
  Cancer of the WBCs
- D.
  
  Abnormal increase in WBCs
- E.
  
  Abnormal increase in RBCs
29.

Anemia
- A.
  
  Abnormal decrease in RBCs
- B.
  
  Abnormal decrease in WBCs
- C.
  
  Cancer of the WBCs
- D.
  
  Abnormal increase in WBCs
- E.
  
  Abnormal increase in RBCs
30.

SMCV (mean cell volume)
- A.
  
  Hgb/HCT (31-37% or gm/dL)
- B.
  
  Hgb/RBC (26-34 pg)
- C.
  
  HCT/RBC (82-98 micrometers/Fl)
31.

MCHC (mean cell hemoglobin concentration)
- A.
  
  Hgb/HCT (31-37% or gm/dL)
- B.
  
  Hgb/RBC (26-34 pg)
- C.
  
  HCT/RBC (82-98 micrometers/Fl)
32.

MCH (mean cell hemoglobin)
- A.
  
  Hgb/HCT (31-37% or gm/dL)
- B.
  
  Hgb/RBC (26-34 pg)
- C.
  
  HCT/RBC (82-98 micrometers/Fl)
33.

Aplastic anemia
- A.
  
  Seen with blood loss (menses, ulcers, hemorrhaging)
- B.
  
  Destruction of circulating RBCs
- C.
  
  Inherited abnormal hemoglobin S
- D.
  
  Caused by decreased vitamin B12
- E.
  
  Destruction of stem cells in bone marrow from toxins
34.

Pernicious anemia
- A.
  
  Seen with blood loss (menses, ulcers, hemorrhaging)
- B.
  
  Destruction of circulating RBCs
- C.
  
  Inherited abnormal hemoglobin S
- D.
  
  Caused by decreased vitamin B12
- E.
  
  Destruction of stem cells in bone marrow from toxins
35.

Hemolytic anemia
- A.
  
  Seen with blood loss (menses, ulcers, hemorrhaging)
- B.
  
  Destruction of circulating RBCs
- C.
  
  Inherited abnormal hemoglobin S
- D.
  
  Caused by decreased vitamin B12
- E.
  
  Destruction of stem cells in bone marrow from toxins
36.

ALL (acute lymphocytic leukemia)
- A.
  
  Sudden cancer of a nongranulocyte
- B.
  
  Presence of atypical “reactive” lymphocytes
- C.
  
  Abnormal decrease of WBCs
- D.
  
  Increase in WBCs (usually due to infection)
- E.
  
  Long-term cancer of granulocytes in bone marrow
37.

Leukocytosis
- A.
  
  Sudden cancer of a nongranulocyte
- B.
  
  Presence of atypical “reactive” lymphocytes
- C.
  
  Abnormal decrease of WBCs
- D.
  
  Increase in WBCs (usually due to infection)
- E.
  
  Long-term cancer of granulocytes in bone marrow
38.

Leukocytopenia
- A.
  
  Sudden cancer of a nongranulocyte
- B.
  
  Presence of atypical “reactive” lymphocytes
- C.
  
  Abnormal decrease of WBCs
- D.
  
  Increase in WBCs (usually due to infection)
- E.
  
  Long-term cancer of granulocytes in bone marrow
39.

CML (chronic myelocytic leukemia)
- A.
  
  Sudden cancer of a nongranulocyte
- B.
  
  Presence of atypical “reactive” lymphocytes
- C.
  
  Abnormal decrease of WBCs
- D.
  
  Increase in WBCs (usually due to infection)
- E.
  
  Long-term cancer of granulocytes in bone marrow
40.

Mononucleosis
- A.
  
  Sudden cancer of a nongranulocyte
- B.
  
  Presence of atypical “reactive” lymphocytes
- C.
  
  Abnormal decrease of WBCs
- D.
  
  Increase in WBCs (usually due to infection)
- E.
  
  Long-term cancer of granulocytes in bone marrow

Back to top